Authors: Pignata, S Frezza, P Tramontana, S Perrone, F Tambaro, R Casella, G Ferrari, E Iodice, F De Vivo, R Ricchi, P Tramontana, F Silvestro, G

Citation: S. Pignata et al., Phase I study with weekly cisplatin-paclitaxel and concurrent radiotherapyin patients with carcinoma of the cervix uteri, ANN ONCOL, 11(4), 2000, pp. 455-459

Authors: Frasci, G D'Aiuto, G Comella, P Thomas, R Capasso, I Di Bonito, M Rivellini, F Carteni, G De Lucia, L Maiorino, L D'Aniello, R Frezza, P Lapenta, L Comella, G

Citation: G. Frasci et al., Cisplatin-epirubicin-paclitaxel weekly administration with G-CSF support in advanced breast cancer. A Southern Italy Cooperative Oncology group (SICOG) phase II study, BREAST CANC, 62(2), 2000, pp. 87-97

Authors: Pignata, S Silvestro, G Ferrari, E Selvaggi, L Perrone, F Maffeo, A Frezza, P Di Vagno, G Casella, G Ricchi, P Cormio, G Gallo, C Iodice, F Romeo, F Fiorentino, R Fortuna, G Tramontana, S

Citation: S. Pignata et al., Phase II study of cisplatin and vinorelbine as first-line chemotherapy in patients with carcinoma of the uterine cervix, J CL ONCOL, 17(3), 1999, pp. 756-760

Authors: De Matteis, A Montella, M Iannuzzo, M De Marco, MR Landi, G Labonia, V Frezza, P Cerra, M Oliviero, P D'Aiuto, G

Citation: A. De Matteis et al., Multimodal treatment strategy for locally advanced breast cancer, J CHEMOTHER, 10(6), 1998, pp. 476-483